{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:31:17Z","timestamp":1793773877841,"version":"4.6.1"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104507"],"award-info":[{"award-number":["82104507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115606","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T06:10:23Z","timestamp":1696659023000},"page":"115606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis"],"prefix":"10.1016","volume":"168","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1690-3090","authenticated-orcid":false,"given":"Dong","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib5","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep."},{"issue":"8","key":"10.1016\/j.biopha.2023.115606_bib6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/ijc.30219","article-title":"Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis","volume":"139","author":"Xie","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115606_bib7","doi-asserted-by":"crossref","first-page":"1127743","DOI":"10.3389\/fimmu.2023.1127743","article-title":"Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115606_bib12","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat. Commun."},{"issue":"17\u201318","key":"10.1016\/j.biopha.2023.115606_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.drudis.2012.05.012","article-title":"Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis","volume":"17","author":"Adorini","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.biopha.2023.115606_bib14","article-title":"Farnesoid x receptor as target for therapies to treat Cholestasis-Induced liver injury","volume":"10","author":"Petrescu","year":"2021","journal-title":"Cells-Basel"},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-016-0616-x","article-title":"Obeticholic acid: First global approval","volume":"76","author":"Markham","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.115606_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/164_2019_227","article-title":"Obeticholic acid: An update of its pharmacological activities in liver disorders","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb. Exp. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2023.115606_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107867","article-title":"The pathophysiological function of non-gastrointestinal farnesoid X receptor","volume":"226","author":"Yan","year":"2021","journal-title":"Pharm. Ther."},{"issue":"17","key":"10.1016\/j.biopha.2023.115606_bib19","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/jm0582221","article-title":"Farnesoid x receptor: From structure to potential clinical applications","volume":"48","author":"Pellicciari","year":"2005","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.biopha.2023.115606_bib20","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1074\/jbc.RA118.004188","article-title":"Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR","volume":"293","author":"Zheng","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2023.115606_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI0214505","article-title":"Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element","volume":"109","author":"Claudel","year":"2002","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.115606_bib22","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hep.30612","article-title":"Bile acid homeostasis in a cholesterol 7alpha-Hydroxylase and sterol 27-Hydroxylase double knockout mouse model","volume":"70","author":"Rizzolo","year":"2019","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib26","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J. Lipid Res"},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib28","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.biopha.2023.115606_bib30","article-title":"Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition","volume":"1867","author":"Li","year":"2022","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cmet.2015.01.007","article-title":"MAFG is a transcriptional repressor of bile acid synthesis and metabolism","volume":"21","author":"de Aguiar Vallim","year":"2015","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.368","article-title":"Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"issue":"49","key":"10.1016\/j.biopha.2023.115606_bib34","doi-asserted-by":"crossref","first-page":"41334","DOI":"10.1074\/jbc.M112.421834","article-title":"Nuclear receptors HNF4\u03b1 and LRH-1 cooperate in regulating cyp7a1 in vivo","volume":"287","author":"Kir","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib36","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1172\/JCI94029","article-title":"RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism","volume":"127","author":"Tarling","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib37","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.30348","article-title":"The epidermal growth factor receptor ligand amphiregulin protects from cholestatic liver injury and regulates bile acids synthesis","volume":"69","author":"Santamar\u00eda","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"2003","key":"10.1016\/j.biopha.2023.115606_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-1119(03)00631-0","article-title":"Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha)","volume":"313","author":"Chen","year":"2003","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib40","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/labinvest.2010.107","article-title":"Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice","volume":"90","author":"Stroeve","year":"2010","journal-title":"Lab. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib41","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J. Lipid Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2023.115606_bib43","doi-asserted-by":"crossref","unstructured":"T. Inagaki, A. Moschetta, Y.K. Lee, L. Peng, G. Zhao, M. Downes, et al., Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor, Proceedings of the National Academy of Sciences 103(10) (2006) 3920\u20133925, https:\/\/doi.org\/10.1073\/pnas.0509592103.","DOI":"10.1073\/pnas.0509592103"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7\u03b1-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.phrs.2010.12.018","article-title":"Tissue-specific function of farnesoid X receptor in liver and intestine","volume":"63","author":"Zhu","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib46","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2018.06.038","article-title":"An FXR agonist reduces bile acid synthesis independently of increases in FGF19 in healthy volunteers","volume":"155","author":"Al-Khaifi","year":"2018","journal-title":"Gastroenterology"},{"issue":"30","key":"10.1016\/j.biopha.2023.115606_bib47","doi-asserted-by":"crossref","first-page":"27703","DOI":"10.1074\/jbc.M302128200","article-title":"Farnesoid x receptor regulates bile Acid-Amino acid conjugation","volume":"278","author":"Pircher","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/03602532.2012.740048","article-title":"Nuclear receptors in bile acid metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile acid sulfation: A pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ab.2008.09.040","article-title":"Formation and biliary excretion of glutathione conjugates of bile acids in the rat as shown by liquid chromatography\/electrospray ionization-linear ion trap mass spectrometry","volume":"384","author":"Mitamura","year":"2009","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2023.115606_bib51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0016-5085(03)00388-3","article-title":"FXR induces the UGT2B4 enzyme in hepatocytes: A potential mechanism of negative feedback control of FXR activity","volume":"124","author":"Barbier","year":"2003","journal-title":"Gastroenterology"},{"issue":"45","key":"10.1016\/j.biopha.2023.115606_bib52","doi-asserted-by":"crossref","first-page":"42549","DOI":"10.1074\/jbc.M107557200","article-title":"Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid x receptor","volume":"276","author":"Song","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115606_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bcp.2017.09.016","article-title":"Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury","volume":"146","author":"Gao","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib54","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bph.14126","article-title":"Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo","volume":"175","author":"Yang","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2133\/dmpk.21.315","article-title":"Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase","volume":"21","author":"Miyata","year":"2006","journal-title":"Drug Metab. Pharm."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2023.115606_bib56","first-page":"84","article-title":"Novel pathways of bile acid metabolism involving CYP3A4","volume":"1687","author":"Bodin","year":"2005","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Cell Biol. Lipids"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/atm-20-4289","article-title":"The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis","volume":"2","author":"Chen","year":"2014","journal-title":"Ann. Transl. Med"},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00008571-200410000-00001","article-title":"Regulation of CYP3A4 by the bile acid receptor FXR: Evidence for functional binding sites in the CYP3A4 gene","volume":"14","author":"Gnerre","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2009.01.006","article-title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","volume":"37","author":"Khan","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib60","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/dmd.114.062836","article-title":"GW4064, an agonist of farnesoid x receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression","volume":"43","author":"Zhang","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: Metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2023.115606_bib62","doi-asserted-by":"crossref","unstructured":"B.V. Jones, M. Begley, C. Hill, C.G.M. Gahan, J.R. Marchesi, Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome, Proceedings of the National Academy of Sciences 105(36) (2008) 13580\u201313585, https:\/\/doi.org\/10.1073\/pnas.0804437105.","DOI":"10.1073\/pnas.0804437105"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854008","article-title":"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice","volume":"13","author":"Streidl","year":"2021","journal-title":"Gut Microbes"},{"issue":"7813","key":"10.1016\/j.biopha.2023.115606_bib65","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"46","key":"10.1016\/j.biopha.2023.115606_bib66","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.3748\/wjg.v26.i46.7338","article-title":"Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients","volume":"26","author":"Li","year":"2020","journal-title":"World J. Gastroentero"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib67","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1038\/s41598-020-64728-4","article-title":"Gut microbiota dysbiosis associated with bile acid metabolism in neonatal cholestasis disease","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep. -Uk"},{"issue":"8","key":"10.1016\/j.biopha.2023.115606_bib68","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","article-title":"Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis","volume":"68","author":"Liao","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.biopha.2023.115606_bib69","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic \u03b3\u03b4 T-Cell receptor\u2013positive cells and pathogenesis of cholestatic liver disease","volume":"154","author":"Tedesco","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.biopha.2023.115606_bib71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib72","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/aem.44.5.1030-1034.1982","article-title":"Specificity of bile salt sulfatase activity from Clostridium sp. Strains S1","volume":"44","author":"Huijghebaert","year":"1982","journal-title":"Appl. Environ. Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib73","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1271\/bbb.58.889","article-title":"Purification and properties of bile acid sulfate sulfatase from Pseudomonas testosteroni","volume":"58","author":"Tazuke","year":"1994","journal-title":"Biosci. Biotechnol. Biochem"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib74","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res"},{"issue":"7797","key":"10.1016\/j.biopha.2023.115606_bib75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib76","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-Dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib77","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G\u2010protein bile acid receptor\u20101 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Pars\u00e9us","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib79","doi-asserted-by":"crossref","first-page":"2172671","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib80","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BJ20110022","article-title":"Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1","volume":"436","author":"Odermatt","year":"2011","journal-title":"Biochem. J."},{"issue":"Supplement 2","key":"10.1016\/j.biopha.2023.115606_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cdn\/nzab033_033","article-title":"The bile acids specifically modulate colonic MUC2 and tight junction protein expression in the human colon cancer cell line","volume":"5","author":"Ma","year":"2021","journal-title":"Curr. Dev. Nutr."},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib82","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J. Lipid Res"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101641","article-title":"Regulatory mechanisms of the bile salt export pump (BSEP\/ABCB11) and its role in related diseases","volume":"45","author":"Ren","year":"2021","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin. Drug Met"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib85","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","article-title":"The bile salt export pump (BSEP) in health and disease","volume":"36","author":"Kubitz","year":"2012","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"issue":"02","key":"10.1016\/j.biopha.2023.115606_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-0030-1253224","article-title":"Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy","volume":"30","author":"Pauli-Magnus","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"2016","key":"10.1016\/j.biopha.2023.115606_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.taap.2016.06.019","article-title":"Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats","volume":"305","author":"Zhang","year":"2016","journal-title":"Toxicol. Appl. Pharm."},{"issue":"35","key":"10.1016\/j.biopha.2023.115606_bib88","doi-asserted-by":"crossref","first-page":"31441","DOI":"10.1074\/jbc.M200474200","article-title":"Lithocholic acid decreases expression of bile salt export pump through farnesoid x receptor antagonist activity","volume":"277","author":"Yu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2023.115606_bib89","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model","volume":"10","author":"Moschetta","year":"2004","journal-title":"Nat. Med."},{"issue":"31","key":"10.1016\/j.biopha.2023.115606_bib90","doi-asserted-by":"crossref","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid x Receptor\/Bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib91","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/jhep.2002.31724","article-title":"Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump","volume":"35","author":"Plass","year":"2002","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2023.115606_bib92","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1194\/jlr.M038323","article-title":"Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor","volume":"54","author":"Song","year":"2013","journal-title":"J. Lipid Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib93","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane x receptor, farnesoid x-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib94","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/toxsci\/kfu151","article-title":"Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures","volume":"141","author":"Liu","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib95","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","article-title":"Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice","volume":"125","author":"Wagner","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib96","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/gast.1996.v110.pm8536857","article-title":"Down-regulation of expression and function of the rat liver Na+\/bile acid cotransporter in extrahepatic cholestasis","volume":"110","author":"Gartung","year":"1996","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib98","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.20594","article-title":"Cytokine-independent repression of rodentNtcp in obstructive cholestasis","volume":"41","author":"Geier","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib99","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.20682","article-title":"Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis","volume":"41","author":"Keitel","year":"2005","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.biopha.2023.115606_bib100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1172\/JCI18945","article-title":"Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis","volume":"112","author":"Liu","year":"2003","journal-title":"J. Clin. Invest"},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib101","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/apt.16602","article-title":"Review article: Therapeutic aspects of bile acid signalling in the gut-liver axis","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Aliment Pharm. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib102","first-page":"G798","article-title":"Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver","volume":"289","author":"Zollner","year":"2005","journal-title":"Am. J. Physiol. -Gastr. L"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib103","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib104","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.117.246033","article-title":"Farnesoid x receptor agonists obeticholic acid and chenodeoxycholic acid increase bile acid efflux in Sandwich-Cultured human hepatocytes: Functional evidence and mechanisms","volume":"365","author":"Guo","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib105","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.23876","article-title":"Liver X receptor \u03b1 and farnesoid X receptor are major transcriptional regulators of OATP1B1","volume":"52","author":"Meyer Zu Schwabedissen","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib106","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1152\/physiol.00020.2008","article-title":"The role of FXR in disorders of bile acid homeostasis","volume":"23","author":"Eloranta","year":"2008","journal-title":"Physiology"},{"issue":"7","key":"10.1016\/j.biopha.2023.115606_bib107","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/gast.2002.33583","article-title":"Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"122","author":"Jung","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib108","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/toxsci\/kfu151","article-title":"Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures","volume":"141","author":"Liu","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib109","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","article-title":"Enterohepatic bile salt transporters in normal physiology and liver disease","volume":"126","author":"Kullak-ublick","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/jhep.2001.23501","article-title":"Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver","volume":"33","author":"Soroka","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib111","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2005.07.022","article-title":"Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides","volume":"44","author":"Zelcer","year":"2006","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib112","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.21158","article-title":"Mrp4\u2212\/\u2212 mice have an impaired cytoprotective response in obstructive cholestasis","volume":"43","author":"Mennone","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib113","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(03)00228-9","article-title":"Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine","volume":"39","author":"Zollner","year":"2003","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib114","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbagrm.2011.01.008","article-title":"Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter","volume":"1809","author":"Renga","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"14","key":"10.1016\/j.biopha.2023.115606_bib115","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"OST alpha-OST beta: A key membrane transporter of bile acids and conjugated steroids","volume":"8","author":"Ballatori","year":"2009","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib116","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OST\u03b1-OST\u03b2: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib117","first-page":"1124","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST\u03b1-OST\u03b2 in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"Am. J. Physiol. -Gastr. L."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib118","first-page":"923","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: Role of FXR-regulated organic solute transporter-\u03b1\/\u03b2 in the adaptive response to bile acids","volume":"290","author":"Zollner","year":"2006","journal-title":"Am. J. Physiol. -Gastr. L."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter \u03b1 deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03602532.2012.748793","article-title":"Nuclear-receptor-mediated regulation of drug- and bile-acid-transporter proteins in gut and liver","volume":"45","author":"Staudinger","year":"2013","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib121","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M500417-JLR200","article-title":"FXR regulates organic solute transporters \u03b1 and \u03b2 in the adrenal gland, kidney, and intestine","volume":"47","author":"Lee","year":"2006","journal-title":"J. Lipid Res"},{"issue":"02","key":"10.1016\/j.biopha.2023.115606_bib122","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0030-1253226","article-title":"Organic solute transporter, OST\u03b1-OST\u03b2: Its role in bile acid transport and cholestasis","volume":"30","author":"Soroka","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib123","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflug. Arch."},{"issue":"36","key":"10.1016\/j.biopha.2023.115606_bib124","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.2005.067389","article-title":"Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis","volume":"55","author":"Hruz","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0168-8278(00)80152-X","article-title":"Downregulation of ileal bile acid absorption in bile-duct-ligated rats","volume":"33","author":"Sauer","year":"2000","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib127","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0016-5085(93)90833-X","article-title":"Negative feedback regulation of the ileal bile acid transport system in rodents","volume":"104","author":"Lillienau","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/bbrc.1996.1141","article-title":"Coordinate regulation of bile acid biosynthetic and recovery pathways","volume":"225","author":"Torchia","year":"1996","journal-title":"Biochem. Bioph. Res. Co."},{"issue":"22","key":"10.1016\/j.biopha.2023.115606_bib129","doi-asserted-by":"crossref","first-page":"19909","DOI":"10.1074\/jbc.M207903200","article-title":"Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib130","first-page":"G60","article-title":"FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade","volume":"288","author":"Li","year":"2005","journal-title":"Am. J. Physiol. -Gastr. L."},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.20295","article-title":"Bile acid-induced negative feedback regulation of the human ileal bile acid transporter","volume":"40","author":"Neimark","year":"2004","journal-title":"Hepatology"},{"issue":"1\u20133","key":"10.1016\/j.biopha.2023.115606_bib132","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbaexp.2006.01.003","article-title":"FTF and LRH-1, two related but different transcription factors in human Caco-2 cells: Their different roles in the regulation of bile acid transport","volume":"1732","author":"Pan","year":"2005","journal-title":"Biochim Biophys. Acta"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib133","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1053\/gast.2002.32982","article-title":"Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor","volume":"122","author":"Hwang","year":"2002","journal-title":"Gastroenterology"},{"issue":"43","key":"10.1016\/j.biopha.2023.115606_bib134","doi-asserted-by":"crossref","first-page":"41930","DOI":"10.1074\/jbc.M306309200","article-title":"Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: Efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein","volume":"278","author":"Kok","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2023.115606_bib135","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.3390\/ijms21217829","article-title":"A Villin-Driven fxr transgene modulates enterohepatic bile acid homeostasis and response to an n-6-Enriched High-Fat diet","volume":"21","author":"Wren","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"51","key":"10.1016\/j.biopha.2023.115606_bib136","doi-asserted-by":"crossref","first-page":"42283","DOI":"10.1074\/jbc.M507454200","article-title":"Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine","volume":"280","author":"Nakahara","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib137","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0004563218817798","article-title":"Bile acids and the metabolic syndrome","volume":"56","author":"McGlone","year":"2019","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.biopha.2023.115606_bib138","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.12688\/f1000research.12449.1","article-title":"Recent advances in understanding bile acid homeostasis","volume":"6","author":"Chiang","year":"2017","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib139","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib140","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23450","article-title":"Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine","volume":"51","author":"Thomas","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115606_bib141","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.12456","article-title":"Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal","volume":"35","author":"Schmitt","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib142","doi-asserted-by":"crossref","first-page":"G295","DOI":"10.1152\/ajpgi.00134.2015","article-title":"Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis","volume":"310","author":"Kong","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib143","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115606_bib144","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI42846","article-title":"Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis","volume":"121","author":"Anakk","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"9","key":"10.1016\/j.biopha.2023.115606_bib145","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41374-020-0439-y","article-title":"Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency","volume":"100","author":"Huang","year":"2020","journal-title":"Lab. Invest."},{"issue":"10","key":"10.1016\/j.biopha.2023.115606_bib146","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.dld.2018.04.009","article-title":"FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice","volume":"50","author":"Zhang","year":"2018","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.115606_bib147","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib148","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2023.115606_bib149","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000450908","article-title":"Intestinal farnesoid x receptor signaling modulates metabolic disease","volume":"35","author":"Gonzalez","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2023.115606_bib150","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2023.115606_bib151","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal Microbiota-Farnesoid x receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115606_bib152","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:14:38Z","timestamp":1779916478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222301404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":152,"alternative-id":["S075333222301404X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115606","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115606"}}